Stocksigma LogoStocksigma Logo

CRISIL Revises Neogen Chemicals' Rating Outlook to Stable Post ₹600 Crore QIP

On 26th Sep'26, CRISIL Ratings reaffirmed Neogen Chemicals Limited's long-term bank facilities (₹680 crore) and NCDs (₹200 crore) at 'CRISIL A-', while

CRISIL Revises Neogen Chemicals' Rating Outlook to Stable Post ₹600 Crore QIP

Neogen Chemicals Ltd · Others (Uncategorized) · 27 Sept 2026, 12:42 am

CRISIL Revises Neogen Chemicals' Rating Outlook to Stable Post ₹600 Crore QIP On 26th Sep'26, CRISIL Ratings reaffirmed Neogen Chemicals Limited's long-term bank facilities (₹680 crore) and NCDs (₹200 crore) at 'CRISIL A-', while revising the outlook to 'Stable' from 'Negative', and reaffirmed its short-term rating at 'CRISIL A2+'. Wholly owned subsidiary Neogen Ionics' ₹1,150 crore bank facilities were reaffirmed at 'CRISIL BBB+/Stable'. The outlook revision reflects a strengthened financial risk profile following a ₹600 crore QIP aimed at debt reduction, post-fire operational stabilization, and key capex commissioning to drive medium-term growth.

Original exchange filing (PDF)

More announcements from Neogen Chemicals Ltd

All Neogen Chemicals Ltd announcements